-
2
-
-
78149320923
-
2010 Focused update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy
-
Dickstein K, Vardas PE, Auricchio A, et al. 2010 Focused update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Eur Heart J 2010; 31: 2677-2687.
-
(2010)
Eur Heart J
, vol.31
, pp. 2677-2687
-
-
Dickstein, K.1
Vardas, P.E.2
Auricchio, A.3
-
3
-
-
36849084209
-
The pathophysiology of acute heart failure-is it all about fluid accumulation?
-
Cotter G, Felker GM, Adams KF, et al. The pathophysiology of acute heart failure-is it all about fluid accumulation? Am Heart J 2008; 155: 9-18.
-
(2008)
Am Heart J
, vol.155
, pp. 9-18
-
-
Cotter, G.1
Felker, G.M.2
Adams, K.F.3
-
4
-
-
33644878033
-
Acute heart failure syndromes: Current state and framework for future research
-
Gheorghiade M, Zannad F, Sopko G, et al. Acute heart failure syndromes: Current state and framework for future research. Circulation 2005; 112: 3958-3968.
-
(2005)
Circulation
, vol.112
, pp. 3958-3968
-
-
Gheorghiade, M.1
Zannad, F.2
Sopko, G.3
-
5
-
-
41149164312
-
Incident heart failure hospitalization and subsequent mortality in chronic heart failure: A propensity-matched study
-
Ahmed A, Allman RM, Fonarow GC, et al. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: A propensity-matched study. J Card Fail 2008; 14: 211-218.
-
(2008)
J Card Fail
, vol.14
, pp. 211-218
-
-
Ahmed, A.1
Allman, R.M.2
Fonarow, G.C.3
-
6
-
-
43249087615
-
Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: Findings from OPTIMIZE-HF
-
Fonarow GC, Abraham WT, Albert NM, et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: Findings from OPTIMIZE-HF. Arch Intern Med 2008; 168: 847-854.
-
(2008)
Arch Intern Med
, vol.168
, pp. 847-854
-
-
Fonarow, G.C.1
Abraham, W.T.2
Albert, N.M.3
-
7
-
-
80054947580
-
Sympathetically mediated changes in capacitance: Redistribution of the venous reservoir as a cause of decompensation
-
Fallick C, Sobotka PA and Dunlap ME. Sympathetically mediated changes in capacitance: Redistribution of the venous reservoir as a cause of decompensation. Circ Heart Fail 2011; 4: 669-675.
-
(2011)
Circ Heart Fail
, vol.4
, pp. 669-675
-
-
Fallick, C.1
Sobotka, P.A.2
Dunlap, M.E.3
-
8
-
-
0032080919
-
Systemic inflammation in patients with heart failure
-
Hasper D, Hummel M, Kleber FX, et al. Systemic inflammation in patients with heart failure. Eur Heart J 1998; 19: 761-765.
-
(1998)
Eur Heart J
, vol.19
, pp. 761-765
-
-
Hasper, D.1
Hummel, M.2
Kleber, F.X.3
-
9
-
-
0017332333
-
Correlative classification of clinical and hemodynamic function after acute myocardial infarction
-
Forrester JS, Diamond GA and Swan HJ. Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cardiol 1977; 39: 137-145.
-
(1977)
Am J Cardiol
, vol.39
, pp. 137-145
-
-
Forrester, J.S.1
Diamond, G.A.2
Swan, H.J.3
-
10
-
-
20044379730
-
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
-
Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416.
-
(2005)
Eur Heart J
, vol.26
, pp. 384-416
-
-
Nieminen, M.S.1
Bohm, M.2
Cowie, M.R.3
-
11
-
-
26044460566
-
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial
-
Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA 2005; 294: 1625-1633.
-
(2005)
JAMA
, vol.294
, pp. 1625-1633
-
-
Binanay, C.1
Califf, R.M.2
Hasselblad, V.3
-
13
-
-
33750731595
-
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure
-
Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006; 296: 2217-2226.
-
(2006)
JAMA
, vol.296
, pp. 2217-2226
-
-
Gheorghiade, M.1
Abraham, W.T.2
Albert, N.M.3
-
14
-
-
84871058843
-
Ultrafiltration in decompensated heart failure with cardiorenal syndrome
-
Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012; 367: 2296-2304.
-
(2012)
N Engl J Med
, vol.367
, pp. 2296-2304
-
-
Bart, B.A.1
Goldsmith, S.R.2
Lee, K.L.3
-
15
-
-
77957730950
-
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure
-
Massie BM, O'Connor CM, Metra M, et al. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 2010; 363: 1419-1428.
-
(2010)
N Engl J Med
, vol.363
, pp. 1419-1428
-
-
Massie, B.M.1
O'Connor, C.M.2
Metra, M.3
-
16
-
-
33947713810
-
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial
-
Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. JAMA 2007; 297: 1319-1331.
-
(2007)
JAMA
, vol.297
, pp. 1319-1331
-
-
Konstam, M.A.1
Gheorghiade, M.2
Burnett, J.C.3
-
17
-
-
79960090547
-
Effect of nesiritide in patients with acute decompensated heart failure
-
O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365: 32-43.
-
(2011)
N Engl J Med
, vol.365
, pp. 32-43
-
-
O'Connor, C.M.1
Starling, R.C.2
Hernandez, A.F.3
-
18
-
-
38949162580
-
Fluid overload in acute heart failure-re-distribution and other mechanisms beyond fluid accumulation
-
Cotter G, Metra M, Milo-Cotter O, et al. Fluid overload in acute heart failure-re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 2008; 10: 165-169.
-
(2008)
Eur J Heart Fail
, vol.10
, pp. 165-169
-
-
Cotter, G.1
Metra, M.2
Milo-Cotter, O.3
-
19
-
-
0024853289
-
Neuroendocrine response in acute heart failure and the influence of treatment
-
Broqvist M, Dahlstrom U, Karlberg BE, et al. Neuroendocrine response in acute heart failure and the influence of treatment. Eur Heart J 1989; 10: 1075-1083.
-
(1989)
Eur Heart J
, vol.10
, pp. 1075-1083
-
-
Broqvist, M.1
Dahlstrom, U.2
Karlberg, B.E.3
-
20
-
-
0141576813
-
Alveolar-capillary membrane dysfunction in heart failure: Evidence of a pathophysiologic role
-
Guazzi M. Alveolar-capillary membrane dysfunction in heart failure: Evidence of a pathophysiologic role. Chest 2003; 124: 1090-1102.
-
(2003)
Chest
, vol.124
, pp. 1090-1102
-
-
Guazzi, M.1
-
21
-
-
0042354582
-
Hypoalbuminemia in elderly patients with acute diastolic heart failure
-
Arques S, Ambrosi P, Gelisse R, et al. Hypoalbuminemia in elderly patients with acute diastolic heart failure. J Am Coll Cardiol 2003; 42: 712-716.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 712-716
-
-
Arques, S.1
Ambrosi, P.2
Gelisse, R.3
-
22
-
-
40849111905
-
Cardiorenal interactions: Insights from the ESCAPE trial
-
Nohria A, Hasselblad V, Stebbins A, et al. Cardiorenal interactions: Insights from the ESCAPE trial. J Am Coll Cardiol 2008; 51: 1268-1274.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1268-1274
-
-
Nohria, A.1
Hasselblad, V.2
Stebbins, A.3
-
23
-
-
10744231948
-
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients
-
Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004; 147: 331-338.
-
(2004)
Am Heart J
, vol.147
, pp. 331-338
-
-
Butler, J.1
Forman, D.E.2
Abraham, W.T.3
-
24
-
-
38949205222
-
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance
-
Metra M, Nodari S, Parrinello G, et al. Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance. Eur J Heart Fail 2008; 10: 188-195.
-
(2008)
Eur J Heart Fail
, vol.10
, pp. 188-195
-
-
Metra, M.1
Nodari, S.2
Parrinello, G.3
-
25
-
-
84903794699
-
Renal dysfunction in acute congestive heart failure: A common problem for cardiologists and nephrologists
-
Graziani G, Pini D, Oldani S, et al. Renal dysfunction in acute congestive heart failure: A common problem for cardiologists and nephrologists. Heart Fail Rev 2014: 19: 699-708.
-
(2014)
Heart Fail Rev
, vol.19
, pp. 699-708
-
-
Graziani, G.1
Pini, D.2
Oldani, S.3
-
26
-
-
84883657695
-
The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction
-
Van Diepen S, Vavalle JP, Newby LK, et al. The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction. Crit Care Med 2013; 41: 2080-2087.
-
(2013)
Crit Care Med
, vol.41
, pp. 2080-2087
-
-
Van Diepen, S.1
Vavalle, J.P.2
Newby, L.K.3
-
27
-
-
34848904566
-
Patterns of weight change preceding hospitalization for heart failure
-
Chaudhry SI, Wang Y, Concato J, et al. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007; 116: 1549-1554.
-
(2007)
Circulation
, vol.116
, pp. 1549-1554
-
-
Chaudhry, S.I.1
Wang, Y.2
Concato, J.3
-
28
-
-
85047932251
-
Continuous infusion versus bolus injection of loop diuretics in congestive heart failure
-
Salvador DR, Rey NR, Ramos GC, et al. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2005: CD003178.
-
(2005)
Cochrane Database Syst Rev
-
-
Salvador, D.R.1
Rey, N.R.2
Ramos, G.C.3
-
29
-
-
79952260198
-
Diuretic strategies in patients with acute decompensated heart failure
-
Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364: 797-805.
-
(2011)
N Engl J Med
, vol.364
, pp. 797-805
-
-
Felker, G.M.1
Lee, K.L.2
Bull, D.A.3
-
30
-
-
78649448385
-
Impact of dopamine infusion on renal function in hospitalized heart failure patients: Results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial
-
Giamouzis G, Butler J, Starling RC, et al. Impact of dopamine infusion on renal function in hospitalized heart failure patients: Results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial. J Card Fail 2010; 16: 922-930.
-
(2010)
J Card Fail
, vol.16
, pp. 922-930
-
-
Giamouzis, G.1
Butler, J.2
Starling, R.C.3
-
31
-
-
78049332540
-
Combination of loop diuretics with thiazide-type diuretics in heart failure
-
Jentzer JC, DeWald TA and Hernandez AF. Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol 2010; 56: 1527-1534.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 1527-1534
-
-
Jentzer, J.C.1
DeWald, T.A.2
Hernandez, A.F.3
-
32
-
-
84890931629
-
Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompensated heart failure
-
Eng M and Bansal S. Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompensated heart failure. Int J Cardiol 2014; 170: e68-e69.
-
(2014)
Int J Cardiol
, vol.170
, pp. e68-e69
-
-
Eng, M.1
Bansal, S.2
-
33
-
-
28244434083
-
Ultrafiltration versus usual care for hospitalized patients with heart failure: The Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial
-
Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: The Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 2005; 46: 2043-2046.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 2043-2046
-
-
Bart, B.A.1
Boyle, A.2
Bank, A.J.3
-
34
-
-
33846811342
-
Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure
-
Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 675-683.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 675-683
-
-
Costanzo, M.R.1
Guglin, M.E.2
Saltzberg, M.T.3
-
36
-
-
84885845957
-
2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines
-
Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128: e240-327.
-
(2013)
Circulation
, vol.128
, pp. e240-e327
-
-
Yancy, C.W.1
Jessup, M.2
Bozkurt, B.3
-
37
-
-
84894057345
-
Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: The Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial
-
Triposkiadis FK, Butler J, Karayannis G, et al. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: The Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial. Int J Cardiol 2014; 172: 115-121.
-
(2014)
Int J Cardiol
, vol.172
, pp. 115-121
-
-
Triposkiadis, F.K.1
Butler, J.2
Karayannis, G.3
-
38
-
-
84890369206
-
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial
-
Chen HH, Anstrom KJ, Givertz MM, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial. JAMA 2013; 310: 2533-2543.
-
(2013)
JAMA
, vol.310
, pp. 2533-2543
-
-
Chen, H.H.1
Anstrom, K.J.2
Givertz, M.M.3
-
39
-
-
46549093415
-
Hemodynamic effects of nitroglycerin and longacting nitrates
-
Abrams J. Hemodynamic effects of nitroglycerin and longacting nitrates. Am Heart J 1985; 110: 216-224.
-
(1985)
Am Heart J
, vol.110
, pp. 216-224
-
-
Abrams, J.1
-
40
-
-
66249133670
-
Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure
-
Den Uil CA, Lagrand WK, Spronk PE, et al. Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure. Eur J Heart Fail 2009; 11: 386-390.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 386-390
-
-
Den Uil, C.A.1
Lagrand, W.K.2
Spronk, P.E.3
-
41
-
-
0032492071
-
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema
-
Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389-393.
-
(1998)
Lancet
, vol.351
, pp. 389-393
-
-
Cotter, G.1
Metzkor, E.2
Kaluski, E.3
-
42
-
-
0029780286
-
Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase
-
Munzel T, Kurz S, Rajagopalan S, et al. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. J Clin Invest 1996; 98: 1465-1470.
-
(1996)
A new action for an old drug. J Clin Invest
, vol.98
, pp. 1465-1470
-
-
Munzel, T.1
Kurz, S.2
Rajagopalan, S.3
-
43
-
-
0025770138
-
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
-
Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-310.
-
(1991)
N Engl J Med
, vol.325
, pp. 303-310
-
-
Cohn, J.N.1
Johnson, G.2
Ziesche, S.3
-
45
-
-
79952193097
-
Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure
-
Chow SL, O'Barr SA, Peng J, et al. Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure. J Cardiac Fail 2011; 17: 181-187.
-
(2011)
J Cardiac Fail
, vol.17
, pp. 181-187
-
-
Chow, S.L.1
O'Barr, S.A.2
Peng, J.3
-
46
-
-
0037027487
-
Nitrate tolerance: A unifying hypothesis
-
Gori T and Parker JD. Nitrate tolerance: A unifying hypothesis. Circulation 2002; 106: 2510-2513.
-
(2002)
Circulation
, vol.106
, pp. 2510-2513
-
-
Gori, T.1
Parker, J.D.2
-
47
-
-
46249114127
-
Sodium nitroprusside for advanced low-output heart failure
-
Mullens W, Abrahams Z, Francis GS, et al. Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol 2008; 52: 200-207.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 200-207
-
-
Mullens, W.1
Abrahams, Z.2
Francis, G.S.3
-
48
-
-
0026044161
-
Monitoring cyanide and thiocyanate concentrations during infusion of sodium nitroprusside in children
-
Linakis JG, Lacouture PG and Woolf A. Monitoring cyanide and thiocyanate concentrations during infusion of sodium nitroprusside in children. Pediatr Cardiol 1991; 12: 214-218.
-
(1991)
Pediatr Cardiol
, vol.12
, pp. 214-218
-
-
Linakis, J.G.1
Lacouture, P.G.2
Woolf, A.3
-
49
-
-
0020026722
-
Effect of shortterm infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure
-
Cohn JN, Franciosa JA, Francis GS, et al. Effect of shortterm infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure. N Engl J Med 1982; 306: 1129-1135.
-
(1982)
N Engl J Med
, vol.306
, pp. 1129-1135
-
-
Cohn, J.N.1
Franciosa, J.A.2
Francis, G.S.3
-
50
-
-
0034721244
-
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure
-
Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000; 343: 246-253.
-
(2000)
Nesiritide Study Group. N Engl J Med
, vol.343
, pp. 246-253
-
-
Colucci, W.S.1
Elkayam, U.2
Horton, D.P.3
-
51
-
-
0037181511
-
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial
-
VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA 2002; 287: 1531-1540.
-
(2002)
JAMA
, vol.287
, pp. 1531-1540
-
-
VMAC Investigators1
-
52
-
-
79960090547
-
Effect of nesiritide in patients with acute decompensated heart failure
-
O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365: 32-43.
-
(2011)
N Engl J Med
, vol.365
, pp. 32-43
-
-
O'Connor, C.M.1
Starling, R.C.2
Hernandez, A.F.3
-
53
-
-
77954623284
-
Relaxin: Review of biology and potential role in treating heart failure
-
Teichman S, Unemori E, Teerlink J, et al. Relaxin: Review of biology and potential role in treating heart failure. Curr Heart Fail Rep 2010; 7: 75-82.
-
(2010)
Curr Heart Fail Rep
, vol.7
, pp. 75-82
-
-
Teichman, S.1
Unemori, E.2
Teerlink, J.3
-
54
-
-
84871986523
-
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): A randomised, placebo-controlled trial
-
Teerlink JR, Cotter G, Davison BA, et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): A randomised, placebo-controlled trial. Lancet 2013; 381: 29-39.
-
(2013)
Lancet
, vol.381
, pp. 29-39
-
-
Teerlink, J.R.1
Cotter, G.2
Davison, B.A.3
-
55
-
-
4043174201
-
The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failure
-
Cotter G, Kaluski E, Stangl K, et al. The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failure. Eur J Heart Fail 2004; 6: 601-609.
-
(2004)
Eur J Heart Fail
, vol.6
, pp. 601-609
-
-
Cotter, G.1
Kaluski, E.2
Stangl, K.3
-
56
-
-
35848944656
-
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: The VERITAS randomized controlled trials
-
McMurray JJ, Teerlink JR, Cotter G, et al. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: The VERITAS randomized controlled trials. JAMA 2007; 298: 2009-2019.
-
(2007)
JAMA
, vol.298
, pp. 2009-2019
-
-
McMurray, J.J.1
Teerlink, J.R.2
Cotter, G.3
-
57
-
-
33947719178
-
Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
-
Gheorghiade M, Konstam MA, Burnett JC, et al. Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 2007; 297: 1332-1343.
-
(2007)
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST Clinical Status Trials. JAMA
, vol.297
, pp. 1332-1343
-
-
Gheorghiade, M.1
Konstam, M.A.2
Burnett, J.C.3
-
58
-
-
27644562291
-
Vasopressin antagonism in heart failure
-
Goldsmith SR and Gheorghiade M. Vasopressin antagonism in heart failure. J Am Coll Cardiol 2005; 46: 1785-1791.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1785-1791
-
-
Goldsmith, S.R.1
Gheorghiade, M.2
-
59
-
-
11144355788
-
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial
-
Gheorghiade M, Gattis WA, O'Connor CM, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial. JAMA 2004; 291: 1963-1971.
-
(2004)
JAMA
, vol.291
, pp. 1963-1971
-
-
Gheorghiade, M.1
Gattis, W.A.2
O'Connor, C.M.3
-
60
-
-
52949114492
-
Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: A doseranging pilot study
-
Goldsmith SR, Elkayam U, Haught WH, et al. Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: A doseranging pilot study. J Cardiac Fail 2008; 14: 641-647.
-
(2008)
J Cardiac Fail
, vol.14
, pp. 641-647
-
-
Goldsmith, S.R.1
Elkayam, U.2
Haught, W.H.3
-
61
-
-
34848887450
-
The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment
-
Dittrich HC, Gupta DK, Hack TC, et al. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Cardiac Fail 2007; 13: 609-617.
-
(2007)
J Cardiac Fail
, vol.13
, pp. 609-617
-
-
Dittrich, H.C.1
Gupta, D.K.2
Hack, T.C.3
-
62
-
-
0037133628
-
BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy
-
Gottlieb SS, Brater DC, Thomas I, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002; 105: 1348-1353.
-
(2002)
Circulation
, vol.105
, pp. 1348-1353
-
-
Gottlieb, S.S.1
Brater, D.C.2
Thomas, I.3
-
63
-
-
44249100426
-
Renal effects of ularitide in patients with decompensated heart failure
-
Lüss H, Mitrovic V, Seferovic PM, et al. Renal effects of ularitide in patients with decompensated heart failure. Am Heart J 2008, 155: 1012.e1-8.
-
(2008)
Am Heart J
, vol.155
, pp. 1012e1-1018e1
-
-
Lüss, H.1
Mitrovic, V.2
Seferovic, P.M.3
-
64
-
-
84872002780
-
Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure
-
Erdmann E, Semigran MJ, Nieminen MS, et al. Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure. Eur Heart J 2013; 34: 57-67.
-
(2013)
Eur Heart J
, vol.34
, pp. 57-67
-
-
Erdmann, E.1
Semigran, M.J.2
Nieminen, M.S.3
-
65
-
-
77955982186
-
CD-NP: An innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease
-
McKie PM, Sangaralingham SJ and Burnett JC Jr. CD-NP: An innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease. Curr Heart Fail Rep 2010; 7: 93-99.
-
(2010)
Curr Heart Fail Rep
, vol.7
, pp. 93-99
-
-
McKie, P.M.1
Sangaralingham, S.J.2
Burnett, J.C.3
|